14 Best Low Risk High Growth Stocks to Buy Right Now

In this article, we discuss the Best Low Risk High Growth Stocks to Buy Right Now.

The US economy is navigating a period of heightened volatility, defined by a sharp geopolitical tax on consumers and a resilient but stressed financial sector. While the first quarter began with a solid footing, recent conflict in the Middle East has disrupted global energy supplies, forcing a pivot in both market sentiment and Federal Reserve policy. Reuters has reported a significant surge in headline inflation expectations. The University of Michigan Surveys of Consumers indicated that year-ahead inflation expectations jumped to 4.8%, the largest one-month increase since 2025. This was primarily driven by a record surge in gasoline receipts at service stations. Consequently, consumer sentiment sank by 11% in April. Reuters noted that Americans across all demographic groups cited the conflict in the Middle East as the primary cause of unfavorable changes to the economy, with assessments of personal finances declining due to high energy prices and weakening asset values.

READ MORE: David Einhorn Stock Portfolio: Top 10 Stock Picks.

Despite the gloom in sentiment, actual spending remained surprisingly buoyant at the start of the quarter. Reuters reported that US retail sales increased 1.7% in March, beating economist expectations. While higher gasoline prices accounted for much of this gain, core retail sales, which exclude volatile categories like autos and building materials, rose by 0.7%. This data suggests that households are leaning on tax refunds and pandemic-era savings to maintain spending, even as the price squeeze intensifies. The Federal Reserve, currently facing a Senate confirmation hearing for nominee Kevin Warsh, has maintained a target interest rate of 3.5%–3.75%. However, Reuters highlights that the vast majority of Fed participants now see elevated upside risks to inflation. Minutes from recent meetings suggest that if the closure of the Strait of Hormuz persists, impacting roughly 20% of global crude flows, the Fed may be forced to delay expected rate cuts or even consider additional hikes to prevent high energy costs from passing through to core inflation.

READ MORE: Mario Gabelli Stock Portfolio: Top 10 Stock Picks.

Our Methodology

For this article, we used stock screeners to make a list of firms with a beta of less than 1 and positive earnings per share growth over the past five years. Data for the hedge fund sentiment surrounding each stock was taken from Insider Monkey’s Q4 2025 database of 1041 elite hedge funds.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 498.7% since May 2014, beating its benchmark by 303 percentage points (see more details here).

Best Low Risk High Growth Stocks to Buy Right Now

14. McDonald’s Corporation (NYSE:MCD)

McDonald’s Corporation (NYSE:MCD) is a 70-year-old brand. It has recently transformed into a data-driven real estate and AI powerhouse, shifting its growth trajectory. The smart money has been pouring into the company because unlike most fast-food chains, McDonald’s is primarily a real estate company. It owns the land under 85% of its restaurants. It leases this land back to franchisees, ensuring a stable, high-margin rent stream that is largely independent of whether a specific store has a bad month in sales. In 2025, the company generated $7.2 billion in free cash flow. This massive liquidity allows it to weather economic downturns, as consumers trade down to McDonald’s value meals when luxury dining becomes too expensive.

McDonald’s Corporation is also becoming a tech-enabled logistics firm. Data shows that by March, the MyMcDonald’s Rewards program had scaled to 210 million active users. This allows for hyper-personalized marketing that has increased visit frequency by 12% in key demographics. Earlier this month, McDonald’s completed the full rollout of generative AI drive-thrus across 8,000 US locations, which has reduced average wait times by 15 seconds per car, a massive efficiency gain in a high-volume business. The company is currently in the first phase of its most ambitious expansion in history. It is on track to open 2,600 new restaurants in 2026 alone, part of a broader goal to hit 50,000 locations by 2027.

13. T-Mobile US, Inc. (NASDAQ:TMUS)

T-Mobile US, Inc. (NASDAQ:TMUS) has been catering to a specific section of the telecom market where other operators are not as reliable. This is the customers who switch specifically for 5G performance rather than price. In early 2026, T-Mobile reported that more customers than ever were selecting its most premium rate plans. This more-for-more strategy is driving Postpaid ARPA (Average Revenue Per Account) growth without requiring the aggressive, margin-crushing promotions seen in previous years. The firm is currently outperforming its 2024 Capital Markets Day plan in rural markets and among corporate users, segments previously dominated by AT&T and Verizon.

READ ALSO: 15 Best Stocks to Buy According to Billionaire Seth Klarman.

T-Mobile US, Inc. is no longer just a phone company. It is stealing market share from cable providers. The firm reached 8 million 5G broadband customers in early 2026 and has raised its long-term target to 15 million by 2030. Through strategic joint ventures and its T-Fiber brand, it is aiming for 3–4 million fiber customers by 2030, creating a dual-threat infrastructure that investors view as a high-margin recurring revenue engine. The 2026 capital allocation program of the company provides a significant safety net for the stock price. In February, T-Mobile authorized an up to $14.6 billion return program for the year, including share repurchases and a quarterly dividend. The Q1 2026 dividend was set at $1.02 per share.

12. Linde plc (NASDAQ:LIN)

Industrial gas companies are often seen as mature businesses. However, Linde plc (NASDAQ:LIN) is considered a mature growth option because of the profile it has in the clean hydrogen and semiconductor gas sectors. The primary safety mechanism for the stock is its contractually secured backlog. In early 2026, Linde reported a record $10 billion project backlog. Because these are long-term, take-or-pay contracts, where customers must pay even if they do not take the gas, it provides a level of earnings certainty that is rare in the industrial sector. Management expects to start up $2.5 billion to $3 billion worth of these projects in 2026 alone, converting secured capital into immediate, high-margin recurring revenue.

The base business of Linde plc (NASDAQ:LIN) provides investors safety, while the company’s leadership in the energy transition provides high growth. Approximately two-thirds of Linde’s backlog is tied to clean energy, specifically hydrogen production and carbon capture. Linde is currently executing some of the world’s largest clean hydrogen projects, such as those in the US Gulf Coast, positioning it to be the infrastructure landlord of the future hydrogen economy. The firm is a critical partner for the AI revolution. Manufacturing advanced AI chips requires ultra-high-purity specialty gases. As semiconductor fabs move to smaller nodes, the gas intensity increases significantly. In Q1 2026, Linde’s electronics segment saw high-single-digit growth, driven by new fab startups in the US and Asia.

11. Philip Morris International Inc. (NYSE:PM)  

Philip Morris International Inc. (NYSE:PM) is moving away from reliance on traditional cigarettes to high-margin, smoke-free technology. The acquisition of Swedish Match has turned the US market into the biggest growth driver for the firm. In early 2026, ZYN nicotine pouches reached a structural milestone, shipping nearly 800 million cans annually. With a retail market share of over 70% in the US, ZYN provides a high-margin revenue stream that is currently growing at double-digit rates. Smoke-free products like ZYN and IQOS carry significantly higher gross margins than traditional cigarettes. As these products now account for over 41% of total net revenue, they are structurally expanding the company’s overall profit profile.

READ ALSO: 12 Best Stocks to Buy According to Billionaire David Abrams.

For risk-averse investors, the core business of Philip Morris International Inc. acts as a financial fortress. Even during economic downturns, nicotine consumption remains steady. PM’s massive global footprint, selling in over 180 markets, provides geographic diversification that protects against localized recessions or currency crashes. The stock is also a favorite among income-focused investors because of its extreme reliability. In late 2025, PM announced an 8.9% dividend hike, the largest in over a decade. As of April, the annual dividend stands at $5.88 per share, yielding approximately 3.7%–3.8%. Management has targeted $45 billion in aggregate operating cash flow through 2028. For a beginner, this visibility means the company has a clear plan to pay its dividend and buy back shares for years to come.

10. International Business Machines Corporation (NYSE:IBM)

Wall Street bigwigs have started treating International Business Machines Corporation (NYSE:IBM) as a high-margin software company rather than a hardware vendor. Earlier this month, IBM guided for 10% revenue growth in its software segment, the highest in the company’s recent history. This is driven by the watsonx AI platform, which now helps over 95% of Fortune 500 companies manage their AI deployments. Its acquisition of Red Hat continues to pay off, with OpenShift, the universal cloud operating layer, reaching a $2 billion annual run rate with 30% growth. This creates sticky recurring revenue that acts as a low-risk buffer.

International Business Machines Corporation has found a lucrative niche: acting as the secure middleman for regulated industries. While consumer AI is volatile, IBM’s watsonx allows banks, governments, and healthcare firms to use AI with strict data sovereignty. This Sovereign Cloud business is largely decoupled from retail spending, providing a low-risk profile. The 2025/2026 rollout of the z17 mainframe has seen a massive upgrade cycle. Mainframe sales accounted for 23% of total revenue last year, providing a surge in cash that funds IBM’s newer growth initiatives. For a beginner, the ultimate sign of low risk is a company that generates more cash than it knows what to do with. For 2026, CFO Jim Kavanaugh raised free cash flow guidance to $15.7 billion. This is the highest cash flow the company has seen in over a decade, providing a cushion for dividends and R&D.

9. Wells Fargo & Company (NYSE:WFC) 

A big growth driver for Wells Fargo & Company in recent months has been the removal of the Federal Reserve’s $1.95 trillion asset cap, which has restricted the bank’s growth since 2018. For the first time in nearly a decade, Wells Fargo can meaningfully grow its loan book. In Q1 2026, average loans grew 10% year-over-year to $996 billion, driven by a 23% surge in commercial and industrial loans. With the cap lifted, WFC is aggressively expanding its CIB segment to compete with JPMorgan and Goldman Sachs. In early 2026, CIB revenue grew 14%, signaling that the bank is successfully pivoting toward high-margin institutional business. The firm is also growing profits by cutting waste.

READ ALSO: 10 Best Stocks to Buy According to Billionaire Rob Citrone.

Wells Fargo & Company CEO Charlie Scharf has overseen nearly six straight years of headcount reductions. This discipline has helped the bank maintain a 67% efficiency ratio even as it invests heavily in technology. Earlier this month, reports surfaced regarding WFC exiting major consent orders related to past housing and risk management failures. For investors, this significantly lowers the headline risk and potential for multi-billion dollar fines. The capital returns program of the bank also deserves a mention. In Q1 2026 alone, Wells Fargo repurchased $4 billion worth of shares, one of the most aggressive buyback programs in the banking sector.

8. Toyota Motor Corporation (NYSE:TM)

Toyota Motor Corporation (NYSE:TM) has played it smart when it comes to electric vehicles. While competitors have struggled with a cooling EV market, the carmaker’s multi-pathway strategy, focusing on hybrids while scaling electric and hydrogen tech, has proven to be a financial masterstroke. The company is currently outperforming rivals who bet exclusively on battery electric vehicles. Toyota is targeting 6.7 million hybrid and plug-in hybrid units by 2028, a 30% increase from its 2026 goals. Hybrids now account for roughly 50–60% of its total output, providing a high-margin growth engine in regions where charging infrastructure remains sparse. In early 2026, Toyota also launched three new battery electric vehicles, including the bZ Woodland SUV, and scaled up the bZ4X.

Toyota Motor Corporation offers a level of stability rarely seen in the cyclical auto industry. In early 2026, Toyota reported annual revenue exceeding $337 billion, maintaining its rank as #1 in the global industry. Despite geopolitical headwinds in the Middle East causing a recent 5% gap-down in price, the company’s operating margins remain resilient at over 8.5%. With a Beta of 0.64, Toyota is significantly less volatile than the broader market. It moves roughly 40% less than the S&P 500, making it a safe-haven during market corrections. The firm offers a 2.8% to 2.9% dividend yield. The payout is well-covered by earnings, and the company has raised its dividend for three consecutive years.

7. Novartis AG (NYSE:NVS)

Following the successful spin-off of its Sandoz generics division in late 2023, Novartis AG (NYSE:NVS) has transformed into a high-margin, pure-play innovative medicines company that is currently outpacing its peers in both pipeline velocity and capital efficiency. In early 2026, Novartis reported that its core growth drivers, Kisqali (breast cancer), Kesimpta (multiple sclerosis), and Pluvicto (radioligand therapy), were seeing explosive growth. Specifically, Kisqali sales surged by 57% and Pluvicto by 42% in constant currencies, providing the high-growth kicker that elite investors look for. The firm has built a massive competitive moat in radioligand therapy. With the FDA-approved Millburn facility scaling up in early 2026, the company is effectively the leader of this high-margin cancer treatment niche.

READ ALSO: D. E. Shaw Stock Portfolio: Top 10 Stocks to Buy.

Novartis AG stock offers utility-like safety combined with tech-like margins. The company achieved a 40.1% core operating margin in 2025/2026, an elite figure that provides a massive buffer against inflationary pressures and R&D costs. It generated $17.6 billion in free cash flow last year. This liquidity allows it to fund mid-sized bolt-on acquisitions, like the $2 billion Excellergy deal in March 2026, without stressing its balance sheet or taking on dangerous debt. Novartis is a premier income sanctuary. In early 2026, it proposed a dividend of CHF 3.70 per share, a 5.7% increase, yielding approximately 3%. It has a decades-long track record of uninterrupted payouts, providing a reliable paycheck for patient holders.

6. Merck & Co., Inc. (NYSE:MRK)

It is no secret that the pharmaceutical industry is facing a super-cliff of patent expirations, Merck & Co., Inc. has successfully de-risked its future by diversifying its oncology portfolio and scaling its multi-billion dollar cardiovascular and vaccine franchises. Elite investors are treating the stock as a growth play due to the launch of Winrevair. Recently released data from the CADENCE trial provided definitive proof-of-concept for Winrevair in treating heart failure with preserved ejection fraction. Analysts predict this drug could capture 2-3 times its original market target, turning it into a $5 billion+ annual revenue powerhouse by 2028. This success is vital because it provides high-margin growth that is entirely independent of Merck’s flagship drug, Keytruda.

Merck & Co., Inc. continues to report double-digit international growth for its HPV vaccine, Gardasil. New long-term efficacy data presented at the EUROGIN 2026 Congress reinforced its status as a non-optional global health utility. Earlier this month, the European Commission approved ENFLONSIA for RSV prevention in infants, positioning Merck to capture a significant share of the multi-billion dollar RSV immunization market. The firm maintains a massive cash flow and a low Beta of 0.26. It is a favorite for income-focused funds, currently trading with a forward P/E of roughly 20x.

5. AstraZeneca PLC (NYSE:AZN)

The growth story for AstraZeneca PLC (NYSE:AZN) is built on a massive, contractually visible expansion plan. Earlier this year, CEO Pascal Soriot reaffirmed the company’s goal to reach $80 billion in annual revenue by 2030. For a company currently reporting roughly $59 billion, this represents an industry-leading growth trajectory. In Q1 2026, cancer drug sales jumped 20%, fueled by blockbuster performance from Tagrisso, Imfinzi, and the accelerating Enhertu portfolio. These high-margin antibody-drug conjugates are viewed by hedge funds as the primary growth engine for the next decade. Safety in pharma comes from having so many products that a single failure cannot sink the stock. AstraZeneca owns 16 different blockbuster medicines, drugs generating over $1 billion annually.

In 2026 alone, AstraZeneca PLC is expecting results from more than 20 Phase III clinical trials. This strategy significantly de-risks the portfolio, as consistent positive readouts, like the recent Tozorakimab and Imfinzi successes in early April, provide a steady stream of new revenue. The firm is also uniquely positioned to handle geopolitical shifts better than many US-centric peers. Despite broader trade tensions, AstraZeneca is the largest multinational pharmaceutical company in China. In early 2026, it pledged an additional $15 billion in investments there, capturing high-volume demand in the world’s second-largest market.

4. HSBC Holdings plc (NYSE:HSBC) 

HSBC Holdings plc (NYSE:HSBC) HSBC has successfully offloaded underperforming western assets, including retail divisions in Canada, France, and parts of the US, to double down on the high-growth corridors of Asia and the Middle East. In early 2026, revenue from its wealth management fees rose 20%, while insurance income jumped 49%. By focusing on new networks in Hong Kong, Singapore, and the UAE, HSBC is capturing the rapid wealth creation of the Asian middle class. Following the removal of balance sheet constraints in early 2026, HSBC’s loan book has seen a broadening out of market leadership. It is now targeting a 17% Return on Tangible Equity (RoTE), a high-performance benchmark for global banks.

READ MORE: 10 Best Stocks to Buy According to Billionaire Paul Tudor Jones.

The stability of HSBC Holdings plc (NYSE:HSBC) comes from its diversified, international footprint which acts as a hedge against any single country’s economic downturn. The bank has guided for $45 billion in Banking Net Interest Income (NII) for 2026, exceeding analyst expectations by $1.5 billion. This is powered by a structural hedge that protects its earnings even if global interest rates begin to fluctuate. The bank maintains a CET1 ratio of 14.9%, significantly above regulatory requirements. This capital cushion ensures the bank can withstand geopolitical volatility, including current disruptions in the Middle East, without compromising its operations.

3. Mastercard Incorporated (NYSE:MA)

Mastercard Incorporated (NYSE:MA) does not issue cards or extend credit, it simply provides the technology that moves money. Because it doesn’t lend money, unlike American Express or Discover, Mastercard has zero exposure to credit card defaults or rising interest rates affecting loan repayments. This makes its business model incredibly stable during economic downturns. In early 2026, Mastercard maintained operating margins above 59%. For every dollar of revenue, nearly 60 cents is pure profit, a level of efficiency usually reserved for software monopolies. Elite investors are also intrigued by digital assets modernization of the firm.

Last month, Mastercard Incorporated announced the acquisition of BVNK for $1.8 billion. This deal is designed to bridge traditional fiat rails with on-chain stablecoin payments. Analysts view this as the next frontier for transaction volume. The company also recently unveiled its Agent Suite, a tool that allows AI agents to securely authorize and execute payments on behalf of businesses, positioning the company as the primary payment rail for the AI economy. The growth of the firm is heavily tied to international travel and global e-commerce, which have hit record highs in 2026. In the 2025 fiscal year, revenue reached nearly $33 billion, up 16.4% year-over-year. Cross-border volume, which carries significantly higher fees than domestic transactions, remains the lead engine for this double-digit growth.

2. Eli Lilly and Company (NYSE:LLY)

Eli Lilly and Company (NYSE:LLY) is often referred to as the leading contender to become the first trillion-dollar pharmaceutical company. Following its massive transformation into a cardiometabolic leader, Lilly is seen as a growth stock in a value sector. This growth is currently being powered by a historic duopoly in the obesity and diabetes markets. In February, Lilly issued 2026 revenue guidance of $80–$83 billion, nearly 4% above consensus. This is driven by the unprecedented demand for Mounjaro and Zepbound. In March, Lilly released Phase 3 data for Foundayo, its once-daily obesity pill. Analysts view this as a massive growth kicker, as it broadens the market to patients who prefer a pill over an injection, significantly increasing the total addressable market. Recent Phase 3 results for retatrutide showed weight loss of up to 16.8%, reinforcing Lilly’s pipeline dominance through the end of the decade.

READ MORE: 15 Best Stocks to Buy According to Billionaire Ray Dalio.

For risk-averse investors, the balance sheet and margins of Eli Lilly and Company provide a tech-like safety net. The firm maintains an elite 83% gross profit margin and a 97% return on equity. This level of profitability allows it to absorb pricing pressures and self-fund its $7 billion+ annual capital expenditures. With a Beta of 0.50, the company is roughly half as volatile as the broader S&P 500. It acts as a defensive safe-haven during market downturns while still offering growth-stock returns. In early 2026, Lilly announced a $3.5 billion investment in a new Lehigh Valley facility. By owning its supply chain, Lilly de-risks itself against the shortages that have plagued competitors like Novo Nordisk.

1. Berkshire Hathaway Inc. (NYSE:BRK-B)

Berkshire Hathaway Inc. (NYSE:BRK-B) is the ultimate all-weather stock. While the company has officially entered the Greg Abel era following Warren Buffett’s transition to Chairman at the start of the year, its bull thesis has actually strengthened due to its massive cash reserves during a period of market volatility. Berkshire is sitting on approximately $350 billion to $373 billion in cash and short-term US Treasuries. This is the highest liquid reserve in corporate history. While waiting for an undervalued acquisition, this cash is not idle. Parked in Treasuries, it is generating over $13 billion in annual risk-free interest income, providing a massive earnings floor that most tech or industrial companies cannot match.

Berkshire Hathaway Inc. often functions as a private economy. Its core insurance units, including GEICO and National Indemnity, are generating record float, money held before claims are paid. In early 2026, premium growth reached 7.4%, providing billions in low-cost capital for Greg Abel to deploy. With the recent completion of the $9.7 billion OxyChem acquisition, Berkshire has added another cash-generative industrial giant to its portfolio, alongside BNSF Railway and Berkshire Hathaway Energy. For the first time in 50 years, there is serious institutional speculation that Berkshire may initiate its first-ever dividend by the end of 2026. This move would likely trigger a massive inflow of capital from dividend-focused index funds, driving the stock price to new highs.

READ NEXT: Billionaire David Tepper’s 10 Small and Midcap Stock Picks with Huge Upside Potential and 10 Best Stocks to Invest In According to Billionaire Steve Cohen.

READ NEXT: Israel Englander Stock Portfolio: Top 10 Stock Picks and Billionaire Stan Druckenmiller’s 10 Small and Mid-Cap Stock Picks with Huge Upside Potential.

Follow Insider Monkey on Google News.